Societe Generale’s Mead Johnson Nutrition Company MJN Stock Holding History

Societe Generale’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$1.28M	Buy	+14,162	New	+$1.2M	0.01%	1139

Other funds holding MJN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Societe Generale's MJN Position: Q2 2016 in Review

Societe Generale opened a new position in Mead Johnson Nutrition Company (MJN) in Q2 2016: 14,162 shares worth $1.28M. The stake represents 0.01% of the portfolio and ranks #1139 among its holdings.

545 funds tracked by Wall St. Rank hold MJN as of Q2 2016.

Societe Generale held 14,162 shares of Mead Johnson Nutrition Company worth $1.28M as of Q2 2016.
Mead Johnson Nutrition Company was a new Societe Generale position in Q2 2016.
Mead Johnson Nutrition Company made up 0.01% of Societe Generale's portfolio in Q2 2016, its #1139 holding.
545 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.